Grants

BMFS-utdelinger

The Bergen Medical Research Foundation has supported medical research at the University of Berge and Helse Bergen HF since 2006, including measures to strengthen the recruitment of highly qualified scientists to medical research in Bergen.

2006

The foundation granted NOK 6,250,000 in 2006:

To the project Links between exocrine and endocrine pancreatic dysfunction: New treatment protocols in common diabetes, Pål Njølstad and Andreas Molven, NOK 2,000,000 per year for 3 years.

Towards international research cooperation on Food Hypersensitivity and Functional Gastrointestinal Disorders, Gülen Arslan, NOK 250,000.

2007

The foundation granted NOK 8,800,000 i 2007, towards:

  • The translational research project: Cancer and mesenchymal stem cells, Rolf Bjerkvig and Per Lønning, NOK 1,500,000 per year in 3 years.
  • The translational research project: The Cardioprotective Role of Insuline Therapy at Reperfusion: An Integrated Genomic and Proteomic Approach to Identify Targets Regulated by Insulin Therapy at Myocardial Reperfusion, Anne K. Jonassen and Jan Erik Nordrehaug, NOK 1,300,000 per year in 3 years.
  • International research cooperation on: Biomedical Screening of Mithochondrial Properties and Redox Status in Living Cells – a High Content Approach, Karl Johan Tronstad, NOK 200,000.
  • International research cooperation at MedVis, Odd Helge Gilja, NOK 200,000.

2008

The foundation granted NOK 12,000,000 in 2008.

To the establishment of Mohn Cancer Research Laboratory, The Faculty of Medicine and Dentistry/Haukeland University Hospital, NOK 3,000,000 per year for 4 years.

2009

Recruitment Programme
The foundation granted in total NOK 13,496,000 the following young researchers in 2009:

  • Lise Gundersen, A translational approach to targeted treatment of diabetes: A node on structural and functional aspects of glucokinase within the Bergen Diabetes Research Group, NOK 1,050,000 per year for 3 years
  • Daniela Elena Costea, Characterization of oral cancer stroma – validation of its molecular signature as prognostic factor and for therapeutic intervention, NOK 1,050,000 per year for 3 years
  • Hrvoje Miletic, Role of EGFR in modulation of cancer stem cell-like and angiogenic brain tumor
    phenotypes,
    NOK 232,000 per year for 3 years
  • Tomas Eagen, Inflammation and Infection in Chronic Obstructive Pulmonary Disease – A Large Cohort Study, NOK 1,050,000 per year for 3 years
  • Xisong Ke, Genome-wide RNA Interference Screen for Molecular Therapeutic Targets of Prostate Carcinogenesis and Metastasis, NOK 1,050,000 per year for 3 years
  • Øyvind Halskau, starting grant, NOK 200,000

2010

Recruitment Programme
The foundation granted in total NOK 19,800,000 to the following young researchers in 2010:

  • Gudbrandsen, Oddrun Anita, Identification of Genes Regulating the Rapid Glycemic Control Induced by Bariatric Surgery, NOK 1,100,000 per year for 3 years
  • Høl, Paul Johan, Clinical biomaterials: Contributing to improved performance and safety of implants, NOK 1,100,000 per year for 3 years
  • Håvik, Bjarte, Brain-expressed Immune Genes in Cognition and Mental Illnesses: Development and Characterization of New Models, NOK 1,100,000 per year for 3 years
  • Kuipers, Sjouke Daouia, BDNF and Neurogenesis in Mood Disorders: ARCing the Gap from Psychopathology to Treatment, NOK 1,100,000 per year for 3 years
  • Wang, Jian, The role of stromal cells in brain tumors after radiotherapy, NOK 1,100,000 per year for 3 years
  • Wolff, Anette Susanne Bøe,Revealing mechanisms of pathological autoimmunity by studying a monogenic autoimmune disease, NOK 1,100,000 per year for 3 years

2011

The foundation granted NOK 49.794.000 towards medical research in 2011.

Recruitment Programme
The foundation granted  NOK 13,200,000 to the following young researchers in 2011:

  • Enger, Martha; Targeting NG2 as a therapy for human Brain Tumours,  NOK 1.100.000 per year for 3 years
  • Knapskog, Stian; Impact of MDM2 Promoter Polymorphisms on Cancer Risk, NOK 1.100.000 per year for 3 years.
  • Svanes, Cecilie; COPD, Asthma and Allergy in Three Generations and Relation to Environmental and Lifestyle Factors, NOK 1.100.000 per year for 3 years.
  • Eikesdal, Hans Petter:  The Role of PTEN and Pseudo PTEN in Response to Breast Cancer Therapy, NOK 1.100.000 per year for 3 years.

Scientific Equipment
The foundation granted NOK 25,344,126 towards the purchase of the following scientific equipment in 2011:

  • Animal-PET, NOK 12,000,000
  • Cardiac-CT,   NOK 13,344,126

Medical Bioinformatics
In the fall of 2011 the foundation granted NOK 9,000,000 to the Faculty of Medicine and Dentistry for the establishment of a research program in medical bioinformatics. Together with NOK 2,250,000 in “gaveforsterkning” from the government and an additional NOK 2,250,000 grant from the foundation, this supports the following three research projects started in 2012:

  • Roland Jonsson; ‘Omics’ Data Analysis and Visualization Group(ODAV): Enabling comprehensive interpretation of global datasets through visualization of biological states within interactive and unbiased networks. NOK 1,500,000 per year for 3 years.
  • Rolv Terje Lie; Methods for Gene-Environment Interaction Studies in Norwegian Biobanks – and their Integration in the Bioinformatics System eSysbio. NOK 1,500,000 per year for 3 years.
  • Vidar Steen; Deep sequencing in biomedicine. NOK 1,500,000 per year for 3 years

2012

Recruitment Programme
The foundation granted in total NOK 6,600,000 to the following young researchers in 2012:

  • Wibrand, Karin; Noncoding RNA in synaptic plasticity and disease, NOK 1.100.000 per year for 3 years.
  • Wang, Xiang; Cell-cell interactions during apoptosis of cancer cells, NOK 1.100.000 per year for 3 years.

2013

Recruitment Programme
The foundation has granted in total NOK 9,900,000 to the following young researchers in 2013:

  • Vibeke Andresen, Molecular Targeted Therapy in Acute Myeloid Leukemia, NOK 1.100.000 per year for 3 years.
  • Kimberley Joanne Hatfield, Characterization of metabolic phenotypes and signaling pathways in acute myeloid leukemia and their role in anti-leukemia treatment, NOK 1.100.000 per year for 3 years.
  • Camilla Krakstad, Improved treatment based on molecular alterations in endometrial cancer, NOK 1.100.000 per year for 3 years.

Comments are closed.